0409-1215-01 |
0409-1215 |
HUMAN PRESCRIPTION DRUG |
Naloxone Hydrochloride |
NALOXONE HYDROCHLORIDE |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
20050712 |
N/A |
ANDA |
ANDA070256 |
Hospira, Inc. |
NALOXONE HYDROCHLORIDE |
.4 mg/mL |
10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1215-01) / 1 mL in 1 VIAL, SINGLE-DOSE (0409-1215-21) |
51662-1242-1 |
51662-1242 |
HUMAN PRESCRIPTION DRUG |
NALOXONE HCI |
NALOXONE HCI |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
20180818 |
N/A |
ANDA |
ANDA070256 |
HF Acquisition Co. LLC, DBA Health First |
NALOXONE HYDROCHLORIDE |
.4 mg/mL |
1 mL in 1 VIAL (51662-1242-1) |
51662-1242-3 |
51662-1242 |
HUMAN PRESCRIPTION DRUG |
NALOXONE HCI |
NALOXONE HCI |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
20200615 |
N/A |
ANDA |
ANDA070256 |
HF Acquisition Co. LLC, DBA Health First |
NALOXONE HYDROCHLORIDE |
.4 mg/mL |
50 POUCH in 1 CASE (51662-1242-3) / 1 mL in 1 POUCH (51662-1242-2) |